| |
| |
|
| Insider
Information: |
Sussman S Donald |
| Relationship: |
|
| City: |
St. Thomas |
| State: |
VI |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
9,234,636 |
|
|
Indirect Shares
|
10,091,314 |
|
|
| Direct
Value |
$269,511,104 |
|
|
|
Indirect Value
|
$145,195,477 |
|
|
| Total
Shares |
19,325,950 |
|
|
| Total
Value |
$414,706,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -8.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alaunos Therapeutics |
TCRT |
10% Owner |
|
0 |
2005-09-13 |
1,214,456 |
Premium* |
|
|
Agilysys Inc |
AGYS |
10% Owner |
2010-07-23 |
3,294,354 |
2008-03-04 |
1,772,286 |
Premium* |
|
|
Accelrys Inc |
ACCL |
10% Owner |
2009-04-16 |
1,598,805 |
2009-04-16 |
1,038,802 |
Premium* |
|
|
Neurobiological Technologies Inc |
NTII |
10% Owner |
2008-11-14 |
3,627,192 |
2008-11-14 |
1,592,865 |
Premium* |
|
|
Arno therapeutics Inc |
ARNI |
|
2016-12-30 |
714,285 |
2016-08-15 |
4,472,905 |
Premium* |
|
|
Eaton Vance Limited Duration Inc... |
EVV |
|
2023-02-21 |
0 |
2023-02-21 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
162 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TCRT |
Alaunos Therapeutics |
10% Owner |
– – • |
2005-09-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,214,456 |
|
- |
|
| ACCL |
Accelrys Inc |
10% Owner |
– – • |
2008-04-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,573,032 |
|
- |
|
| ACCL |
Accelrys Inc |
10% Owner |
– – • |
2008-04-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,220,095 |
|
- |
|
| NTII |
Neurobiological Technolog... |
10% Owner |
– – • |
2008-11-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,592,865 |
|
- |
|
| NTII |
Neurobiological Technolog... |
10% Owner |
– – • |
2008-11-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,627,192 |
|
- |
|
| ARNI |
Arno therapeutics Inc |
See Footnote 1 |
– – • |
2016-08-15 |
4 |
B |
$0.00 |
$0 |
D/D |
714,285 |
714,285 |
2.37 |
- |
|
| ARNI |
Arno therapeutics Inc |
See Footnote 1 |
• • – |
2016-12-30 |
4 |
S |
$0.00 |
$0 |
D/D |
(4,285,111) |
714,285 |
0 |
- |
|
| AGYS |
Agilysys Inc |
10% Owner |
– – • |
2010-07-23 |
4 |
AB |
$7.24 |
$36 |
D/D |
5 |
3,294,354 |
0 |
- |
|
| ACCL |
Accelrys Inc |
10% Owner |
– – • |
2009-04-13 |
4 |
S |
$4.47 |
$1,162 |
I/I |
(260) |
1,122,165 |
0 |
- |
|
| AGYS |
Agilysys Inc |
10% Owner |
– – • |
2008-11-26 |
4 |
B |
$2.71 |
$1,357 |
D/D |
500 |
2,406,801 |
2.37 |
- |
|
| ACCL |
Accelrys Inc |
10% Owner |
– – • |
2009-04-13 |
4 |
S |
$4.47 |
$1,788 |
D/D |
(400) |
1,730,805 |
0 |
- |
|
| ACCL |
Accelrys Inc |
10% Owner |
– – • |
2009-04-08 |
4 |
S |
$4.06 |
$6,251 |
I/I |
(1,539) |
1,130,082 |
0 |
- |
|
| ACCL |
Accelrys Inc |
10% Owner |
– – • |
2008-04-30 |
4 |
B |
$5.60 |
$7,280 |
D/D |
1,300 |
1,603,158 |
2.37 |
- |
|
| ACCL |
Accelrys Inc |
10% Owner |
– – • |
2009-04-08 |
4 |
S |
$4.06 |
$10,155 |
D/D |
(2,500) |
1,743,305 |
0 |
- |
|
| ACCL |
Accelrys Inc |
10% Owner |
– – • |
2009-03-15 |
4 |
S |
$3.42 |
$12,628 |
I/I |
(3,696) |
1,368,526 |
0 |
- |
|
| ACCL |
Accelrys Inc |
10% Owner |
– – • |
2009-03-12 |
4 |
S |
$3.34 |
$13,029 |
I/I |
(3,900) |
1,384,692 |
0 |
- |
|
| ACCL |
Accelrys Inc |
10% Owner |
– – • |
2008-08-27 |
4 |
B |
$5.00 |
$14,642 |
D/D |
2,930 |
2,389,205 |
2.37 |
- |
|
| ACCL |
Accelrys Inc |
10% Owner |
– – • |
2009-03-11 |
4 |
S |
$3.35 |
$15,246 |
I/I |
(4,548) |
1,388,592 |
0 |
- |
|
| ACCL |
Accelrys Inc |
10% Owner |
– – • |
2009-03-24 |
4 |
S |
$3.64 |
$17,814 |
I/I |
(4,900) |
1,323,656 |
0 |
- |
|
| ACCL |
Accelrys Inc |
10% Owner |
– – • |
2009-04-06 |
4 |
S |
$4.14 |
$17,898 |
I/I |
(4,325) |
1,138,321 |
0 |
- |
|
| ACCL |
Accelrys Inc |
10% Owner |
– – • |
2009-03-13 |
4 |
S |
$3.47 |
$20,149 |
I/I |
(5,800) |
1,378,892 |
0 |
- |
|
| ACCL |
Accelrys Inc |
10% Owner |
– – • |
2009-03-15 |
4 |
S |
$3.42 |
$20,158 |
D/D |
(5,900) |
2,119,605 |
0 |
- |
|
| ACCL |
Accelrys Inc |
10% Owner |
– – • |
2009-03-12 |
4 |
S |
$3.34 |
$20,378 |
D/D |
(6,100) |
2,145,105 |
0 |
- |
|
| ACCL |
Accelrys Inc |
10% Owner |
– – • |
2009-03-05 |
4 |
S |
$3.23 |
$20,924 |
I/I |
(6,473) |
1,437,744 |
0 |
- |
|
| ACCL |
Accelrys Inc |
10% Owner |
– – • |
2009-03-14 |
4 |
S |
$3.39 |
$22,601 |
I/I |
(6,670) |
1,372,222 |
0 |
- |
|
162 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
